Literature DB >> 78718

Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.

M G Britton, D W Empey, G C John, K A McDonnell, D T Hughes.   

Abstract

1 Nasal airway resistance (NAR) was measured by anterior rhinometry in ten volunteers with allergic rhinitis. Measurements before and after challenge with three concentrations of histamine diphosphate showed significant rises in NAR for each challenge. 2 In a double-blind, crossover study with the same patients triprolidine (2.5 mg) and pseudoephedrine (60 mg) were shown to be equally effective in reducing the rise in NAR produced by histamine challenge to one nostril; both were significantly better than placebo. 3 The rise in NAR of both nostrils after histamine challenge to one nostril was significantly reduced after pseudoephedrine compared with placebo. This suggests that pseudoephedrine is effective in preventing reflex mucosal congestion in the unchallenged nostril. 4 No increase in the pulse rate or blood pressure of the volunteers was detected after either drug.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78718      PMCID: PMC1429389          DOI: 10.1111/j.1365-2125.1978.tb01681.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  MEASUREMENT OF NASAL AIRWAY RESISTANCE.

Authors:  W R SOLOMON; J A MCLEAN; C COOKINGHAM; G AHRONHEIM; G R DEMUTH
Journal:  J Allergy       Date:  1965 Jan-Feb

2.  The work of breathing through the nose.

Authors:  J BUTLER
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

3.  Nasal decongestant activity of pseudoephedrine.

Authors:  R P Roth; E I Cantekin; C D Bluestone; R M Welch; Y W Cho
Journal:  Ann Otol Rhinol Laryngol       Date:  1977 Mar-Apr       Impact factor: 1.547

4.  The evaluation of histamine antagonists in man.

Authors:  A S Fowle; D T Hughes; G J Knight
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

5.  Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose.

Authors:  G Taylor; A R Macneil; D L Freed
Journal:  J Allergy Clin Immunol       Date:  1973-10       Impact factor: 10.793

6.  Effects of cold air and carbon dioxide on nasal air flow resistance.

Authors:  Y Takagi; D F Proctor; S Salman; S Evering
Journal:  Ann Otol Rhinol Laryngol       Date:  1969-02       Impact factor: 1.547

7.  Comparative effects of transient body surface cooling, recumbency, and induced obstruction in allergic rhinitis and control subjects.

Authors:  W R Solomon
Journal:  J Allergy       Date:  1966-04

8.  An instrument for measuring the effective cross-sectional nasal airway.

Authors:  J T Connell
Journal:  J Allergy       Date:  1966-03

Review 9.  The upper airways. I. Nasal physiology and defense of the lungs.

Authors:  D F Proctor
Journal:  Am Rev Respir Dis       Date:  1977-01

10.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.

Authors:  D W Empey; L A Laitinen; L Jacobs; W M Gold; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1976-02
  10 in total
  16 in total

1.  Cardiovascular effects of a chlorpheniramine/paracetamol combination in hypertensive patients who were sensitive to the pressor effect of pseudoephedrine.

Authors:  S S Chua; S I Benrimoj; R D Gordon; G Williams
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies.

Authors:  S H Thomas; K L Clark; R Allen; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 3.  Nasal provocation.

Authors:  U Pipkorn
Journal:  Clin Rev Allergy       Date:  1988

4.  Nasal decongestants.

Authors:  D W Empey; K T Medder
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

5.  Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.

Authors:  C E Austin; J C Foreman
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

6.  Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge.

Authors:  D W Empey; M F Frosolono; D T Hughes; J G Perkins
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

7.  Assessment of the nasal passages.

Authors:  D W Empey
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.

Authors:  J W Dear; S Ghali; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 9.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08

10.  Nasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative study.

Authors:  O J Corrado; C A Gould; J Y Kassab; R J Davies
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.